- Category
- Micro (2021-22)
- Udyam number
- UDYAM-MH-33-0193956

Ruso Pharma Private Limited
About Ruso Pharma Private Limited
Data last updated:
Ruso Pharma Private Limited is a private limited company based in Navi Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 22 February 2022.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24239MH2022PTC377317.
The company has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Sanket Khandu Varal and Ritik Vasant Jain.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Shop No 1408 Real Tech Park Plot No 39/2 Sector – 30A Vashi, Navi Mumbai, Maharashtra, India – 400705.
As per the financials filed for FY 2025, the company reported a revenue of ₹66.5 Lakh, a decline of 5% compared to the previous year. For the same year it recorded a net loss of ₹1.58 Cr (net margin -237.7%) and EBITDA of -₹1.56 Cr (EBITDA margin -234.5%).
Ruso Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-33-0193956).
Company details
Recognitions & Rankings of Ruso Pharma
Contact details
Ruso Pharma Private Limited's registered office is in Navi Mumbai, Maharashtra.
- Registered AddressShop No 1408 Real Tech Park Plot No 39/2 Sector – 30A Vashi, Navi Mumbai, Maharashtra, India – 400705
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Ruso Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Ruso Pharma Private Limited, buy the company report.
Financials of Ruso Pharma Private Limited
FY 2025 filings availableRuso Pharma Private Limited reported revenue of ₹66.5 Lakh (down 5% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 5% in the latest year. EBITDA rose 27% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | -₹1.56 Cr | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹1.58 Cr | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | -234.5% | |||
| Net Profit Margin | -237.7% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Ruso Pharma Private Limited, buy the company report.
Board of directors of Ruso Pharma Private Limited
Ruso Pharma has 4 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sanket Khandu Varal Also directs: Calyx Chemicals and Pharmaceuticals Limited | Director | 05 Mar 2022 | 4 Years 8 Months | Current |
| Ritik Vasant Jain Also directs: Calyx Chemicals and Pharmaceuticals Limited | Director | 05 Mar 2022 | 4 Years 8 Months | Current |
| Vasant Ghisulal Jain | Director | 22 Feb 2022 | 4 Years 8 Months | Current |
| Khandu Vishnu Varal | Director | 22 Feb 2022 | 4 Years 8 Months | Current |
Peer comparison
Ruso Pharma Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Astronix Healthcare Private Limited | ₹67.07 Lakh (FY 2019) | Kolkata, West Bengal, India | ||||
| Ruso Pharma Private Limitedthis company | ₹66.5 Lakh (FY 2025) | -₹1.58 Cr | -237.7% | -5.0% | Navi Mumbai, Maharashtra, India | |
| Greenenvy Healthcare Private Limited | ₹66.19 Lakh (FY 2025) | -71.0% | Mangalore, Karnataka, India | |||
| G and B Pharmaceuticals Private Limited | ₹65.84 Lakh (FY 2023) | 294.0% | Jagadhri, Haryana, India | |||
| Calsita Futuristic Private Limited | ₹65.57 Lakh (FY 2025) | 91.0% | Vadodara, Gujarat, India |
To see the full peer comparison of Ruso Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Ruso Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Ruso Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Ruso Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Ruso Pharma Private Limited has 6 board changes on record since 2022: 4 appointments and 2 cessations. The latest: Ritik Vasant Jain ceased to be Additional Director on 29 Sep 2023.
Frequently asked questions
Ruso Pharma is an active private limited company based in Navi Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 22 February 2022 (4+ years old) and is registered under CIN U24239MH2022PTC377317.
Ruso Pharma has 4 current directors:
- Sanket Khandu Varal - Director
- Ritik Vasant Jain - Director
- Vasant Ghisulal Jain - Director
- Khandu Vishnu Varal - Director
The latest financial statements of Ruso Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The CIN (Corporate Identification Number) of Ruso Pharma is U24239MH2022PTC377317. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ruso Pharma was incorporated on 22 February 2022, making it 4+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Ruso Pharma by revenue are Astronix Healthcare Private Limited, Greenenvy Healthcare Private Limited, G and B Pharmaceuticals Private Limited, Calsita Futuristic Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Ritik Vasant Jain ceased to be Additional Director on 29 Sep 2023. Sanket Khandu Varal ceased to be Additional Director on 29 Sep 2023. Ritik Vasant Jain was appointed as Director on 05 Mar 2022. Ruso Pharma has 6 board changes on record in total.
Yes, Ruso Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-33-0193956).
The registered office of Ruso Pharma is at Shop No 1408 Real Tech Park Plot No 392 Sector – 30A Vashi, Navi Mumbai, Maharashtra, India – 400705.
Ruso Pharma operates in the pharma industry, in the drug formulation and development segment.
Ruso Pharma can be reached at its registered office: Shop No 1408 Real Tech Park Plot No 392 Sector – 30A Vashi, Navi Mumbai, Maharashtra, India – 400705.

